Conceptio › Archive › ClinicalTrials.gov
ClinicalTrials.govpublic full text

Study to Evaluate the Safety and Efficacy of Serplulimab Plus Bevacizumab and Chemotherapy in NSCLC Patients With Brain Metastases

Sun Yat-sen University · 2023
ClinicalTrials.gov · Datasets · License: Public Domain · 2023
Open Source ↗
efficacyimmunotherapynon-small-cell-lung-cancer
non-small cell lung cancer stage ii, bevacizumab, immunotherapy, brain metastases, serplulimab, efficacy, non-small cell lung cancer, interventional, phase2, phase3
This document is indexed with metadata only — full text is not available in the archive for this record. Open the official source ↗

Related documents

Record · ID 867127
Retrieved via Conceptio — every document is proof-bundled with source, license, and retrieval metadata.